Company intelligence / Profile preview

AireHealth

Winter Park, Florida, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

AireHealth’s FDA-cleared Bluetooth-enabled nebulizer (VitalMed) and VitalBreath platform support symptom tracking, adherence, early detection of respiratory decline, and remote patient monitoring. Company merged with BreathResearch to incorporate AI-based diagnostics and sound analysis into its platform. No active clinical trials or drug programs reported; platform was operational and commercialized before asset auction.

Therapeutic areas: Pulmonology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

BreathResearch (merged)

Beyond the preview

Go deeper on AireHealth.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AireHealth.

Explore the full profile